The MedicX Fund Limited Notice of dividend (2900V)
02 November 2017 - 1:14AM
UK Regulatory
TIDMMXF
RNS Number : 2900V
The MedicX Fund Limited
01 November 2017
Press Release
For immediate release
1 November 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Notice of dividend
The Directors have approved a quarterly dividend of 1.5p per
Ordinary Share in respect of the period 1 July 2017 to 30 September
2017. This will bring the total dividends declared in respect of
the financial year ended 30 September 2017 to 6.0p per Ordinary
Share, an increase of 0.84% over the dividends totalling 5.95p
declared for the previous year ended 30 September 2016. The
dividend will be paid on 29 December 2017 to ordinary shareholders
on the register as at 17 November 2017 (the "Record Date"). The
corresponding ex-dividend date will be 16 November 2017.
The Company is offering qualifying shareholders the opportunity
to take new ordinary shares in the Company, credited as fully paid,
in lieu of the cash dividend to be paid on 29 December 2017, by
participating in the Scrip Dividend Scheme (the "Scheme")
previously put in place by the Company on 5 May 2010. Following the
Company's notice of entry into the UK REIT regime effective from 1
October 2017, the Scrip Dividend Scheme Document was updated to
illustrate to shareholders the mechanics of the possibility of a
scrip alternative being offered on a dividend which is paid partly
or fully as a Property Income Distribution ("PID") as well as a
link to www.signalshares.com where shareholders can elect online to
receive their dividend in the form of new shares rather than
cash.
The option to participate will be available to shareholders
until 6 December 2017 (the "election date"). Further information on
the Scheme, together with a copy of the Scheme Document (which
contains the terms and conditions of the Scheme) and relevant
mandate form document, is available for inspection at the National
Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through
the Scrip Dividend portal on the Company's website
(http://www.medicxfund.com/investors/scrip-dividend-scheme.aspx)
No PID is included in this final dividend for the year ended 30
September 2017.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7 billion of funds for more than 50,000 retail and institutional
investors as well as supplying energy to more than 100,000
customers
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVMMMGMDMGGNZM
(END) Dow Jones Newswires
November 01, 2017 10:14 ET (14:14 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024